Meeting NewsVideo

VIDEO: Spotlight on similarities, differences of obesity- and diabetes-related cancers

LOS ANGELES — In this video exclusive, Derek LeRoith, MD, PhD, professor of medicine and endocrinology and director of research in the endocrine division at Mount Sinai in New York, discusses hyperinsulinemia as a risk factor for cancer.

At the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease, LeRoith, an Endocrine Today Editorial Board Member, presented evidence from epidemiological studies demonstrating that “one of the major risk factors [for cancer] was indeed endogenous hyperinsulinemia. Most of our obese and diabetic patients have insulin resistance and this leads to hyperinsulinemia, which can stimulate cancer cells.”

Watch the video for more.

LOS ANGELES — In this video exclusive, Derek LeRoith, MD, PhD, professor of medicine and endocrinology and director of research in the endocrine division at Mount Sinai in New York, discusses hyperinsulinemia as a risk factor for cancer.

At the World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease, LeRoith, an Endocrine Today Editorial Board Member, presented evidence from epidemiological studies demonstrating that “one of the major risk factors [for cancer] was indeed endogenous hyperinsulinemia. Most of our obese and diabetic patients have insulin resistance and this leads to hyperinsulinemia, which can stimulate cancer cells.”

Watch the video for more.

    See more from World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease